All content for OncoTalks | Oncology Insights at Your Fingertips is the property of Ontada Learn and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Case Journey: How ADCs are Transforming HER2-Low Metastatic Breast Cancer Treatment
OncoTalks | Oncology Insights at Your Fingertips
14 minutes 24 seconds
7 months ago
Case Journey: How ADCs are Transforming HER2-Low Metastatic Breast Cancer Treatment
Introducing a new and exciting video podcast experience: OncoTalks Case Journey. Tune into our debut episode as Dr. Paul Conkling and Dr. Mabel Mardones discuss two compelling cases of metastatic ER-positive breast cancer, emphasizing the role of antibody drug conjugates (ADCs) in treatment. They explore the challenges of HER2-low classification and the importance of early access to innovative therapies for improving patient outcomes. The conversation highlights the need for precise diagnostic approaches and the evolving landscape of breast cancer.
